Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Ibuprofen Market: By Indication, By Route of Administration, By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others, and Geography
Ibuprofen Market size was valued at US$ 6832 Mn in 2023 and poised to grow at a significant CAGR 7.6% from 2024-2030. Rising adoption of an intravenous drug delivery mode for acute pain management owing to faster commencement of action as associated with the additional routes (oral and transdermal mode of administration) as well as the targeted property of drug delivery. IV Ibuprofen progresses the management in pain through less dependency on opioid painkilling medicine, which may lead to numerous complications of health including sedation, dizziness, and others. Caldolor (Cumberland Pharmaceuticals) is predominantly an injectable Ibuprofen drug accessible in the market; henceforth, it partakes enormous demand with slight competition. However, prolonged processes for approval coupled with restricted approvals in certain countries are projected to restraint the market growth. Key players in the global Ibuprofen market enhance their product portfolio and consumer base by adopting striking market strategies like collaborations, acquisitions, and technological innovations, among others. For instance, on Feb 04, 2015- Harbin Gloria Pharma will pay a considerable amount to acquire a maximum stake in Shanxi Powerdone, which makes chemical drugs and compound preparations.
This report gives a comprehensive outlook on Ibuprofen across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa. This report gives historical, current, and future market sizes (US$ Mn) based on application, formula type, and regions. This report studies global Ibuprofen market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the global Ibuprofen market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed global Ibuprofen market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global Ibuprofen market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global Ibuprofen products.
Study Period
2024-2030Base Year
2023CAGR
7.6%Largest Market
North AmericaFastest Growing Market
Europe
Ibuprofen are predominantly used for various health complications such as pain, fever, inflammation, others. Treatment of inflammation with the aid of Ibuprofen is one of the major applications. Ibuprofen is generally used besides most often recommended NSAID.2,3 It is a non-selective inhibitor of cyclo-oxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2).4 Though its anti-inflammatory properties might be weaker as compared to the other NSAIDs, it devours a conspicuous analgesic and antipyretic role. Its effects are in arrears to the inhibitory actions on cyclo-oxygenases, which are involved in the synthesis of prostaglandins. Prostaglandins have a significant part in the production of fever, pain, inflammation.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market CAGR |
7.6% |
By Indication |
|
By Route of Administration |
|
By Distribution Channel |
|
Download Free Sample Report
The ibuprofen market size was valued at US$ 6832 million in 2023
Cumberland Pharmaceuticals Inc, Alveda Pharmaceuticals, Inc. (Acquired by Teligent, Inc.), CSL Limited, Sandor Medicaids Pvt. Ltd., Soho Industri Pharmasi, Germin MED
North America is the fastest-growing region for ibuprofen market
1. Executive Summary |
2. Ibuprofen Market Introduction |
2.1.Global Ibuprofen Market - Taxonomy |
2.2.Global Ibuprofen Market - Definitions |
2.2.1.Indication |
2.2.2.Route of Administration |
2.2.3.Distribution Channel |
2.2.4.Region |
3. Global Ibuprofen Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Ibuprofen Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Ibuprofen Market By Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Fever |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Inflammation |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Pain |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Ibuprofen Market By Route of Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Oral |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Parenteral |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Ibuprofen Market By Distribution Channel , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospital Pharmacies, |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Retail Pharmacies, |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Online Pharmacies |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. others |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Ibuprofen Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Ibuprofen Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Fever |
9.1.2.Inflammation |
9.1.3.Pain |
9.2. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Oral |
9.2.2.Parenteral |
9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital Pharmacies, |
9.3.2.Retail Pharmacies, |
9.3.3.Online Pharmacies |
9.3.4.others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Ibuprofen Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Fever |
10.1.2.Inflammation |
10.1.3.Pain |
10.2. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Oral |
10.2.2.Parenteral |
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital Pharmacies, |
10.3.2.Retail Pharmacies, |
10.3.3.Online Pharmacies |
10.3.4.others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Ibuprofen Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Fever |
11.1.2.Inflammation |
11.1.3.Pain |
11.2. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Oral |
11.2.2.Parenteral |
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital Pharmacies, |
11.3.2.Retail Pharmacies, |
11.3.3.Online Pharmacies |
11.3.4.others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Ibuprofen Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Fever |
12.1.2.Inflammation |
12.1.3.Pain |
12.2. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Oral |
12.2.2.Parenteral |
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital Pharmacies, |
12.3.2.Retail Pharmacies, |
12.3.3.Online Pharmacies |
12.3.4.others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Ibuprofen Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Fever |
13.1.2.Inflammation |
13.1.3.Pain |
13.2. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Oral |
13.2.2.Parenteral |
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital Pharmacies, |
13.3.2.Retail Pharmacies, |
13.3.3.Online Pharmacies |
13.3.4.others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M&A, Strategies, and SWOT Analysis) |
14.2.1.Cumberland Pharmaceuticals Inc. |
14.2.2.Alveda Pharmaceuticals, Inc. (Acquired by Teligent, Inc.) |
14.2.3.CSL Limited |
14.2.4 Sandor Medicaids Pvt. Ltd. |
14.2.5.Soho Industri Pharmasi |
14.2.6.Germin MED |
14.2.7.Grifols S.A. |
14.2.8.Harbin Gloria Pharmaceuticals Co., Ltd. |
14.2.9.Al Nabeel International Ltd |
14.2.10.Laboratorios Valmorca, C.A |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players